Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
Crossref DOI link: https://doi.org/10.1007/s40273-014-0175-5
Published Online: 2014-06-04
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gómez-Outes, Antonio
Avendaño-Solá, Cristina
Terleira-Fernández, Ana Isabel
Vargas-Castrillón, Emilio
Text and Data Mining valid from 2014-06-04